T
RMD icon

Tidemark’s ResMed RMD Stock Holding History

Tidemark’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25K Buy
+10
New +$2.49K ﹤0.01% 646
2024
Q2 		– Sell
-771
Closed -$153K – 707
2024
Q1 		$153K Hold
771
– – 0.09% 140
2023
Q4 		$133K Buy
+771
New +$118K 0.08% 137

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tidemark's RMD Position: Q1 2026 in Review

Tidemark opened a new position in ResMed (RMD) in Q1 2026: 10 shares worth $2.25K. The stake represents ﹤0.01% of the portfolio and ranks #646 among its holdings. This is a return to the name: Tidemark previously reported a position in RMD as recently as Q1 2024.

Tidemark first reported a position in RMD in Q4 2023 and has held it in 3 quarters since. The position peaked at $153K in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Tidemark held 10 shares of ResMed worth $2.25K as of Q1 2026.
  • ResMed was a new Tidemark position in Q1 2026.
  • ResMed made up ﹤0.01% of Tidemark's portfolio in Q1 2026, its #646 holding.
  • Tidemark first reported a position in ResMed in Q4 2023 and has held it in 3 quarters since.
  • Tidemark's ResMed position peaked at $153K in Q1 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.